Maternal prenatal depression is associated with decreased placental expression of the imprinted gene PEG3

Janssen, Anna, Capron, Lauren E., O'Donnell, Kieran, Tunster, Simon J. ORCID: https://orcid.org/0000-0002-2242-9452, Ramchandani, Paul G., Alexander, Heazell E. P., Glover, Vivette and John, Rosalind Margaret ORCID: https://orcid.org/0000-0002-3827-7617 2016. Maternal prenatal depression is associated with decreased placental expression of the imprinted gene PEG3. Psychological Medicine 46 (14) , pp. 2999-3011. 10.1017/S0033291716001598

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (475kB) | Preview

Abstract

Background Maternal prenatal stress during pregnancy is associated with fetal growth restriction and adverse neurodevelopmental outcomes, which may be mediated by impaired placental function. Imprinted genes control fetal growth, placental development, adult behaviour (including maternal behaviour) and placental lactogen production. This study examined whether maternal prenatal depression was associated with aberrant placental expression of the imprinted genes paternally expressed gene 3 (PEG3), paternally expressed gene 10 (PEG10), pleckstrin homology-like domain family a member 2 (PHLDA2) and cyclin-dependent kinase inhibitor 1C (CDKN1C), and resulting impaired placental human placental lactogen (hPL) expression. Method A diagnosis of depression during pregnancy was recorded from Manchester cohort participants’ medical notes (n = 75). Queen Charlotte's (n = 40) and My Baby and Me study (MBAM) (n = 81) cohort participants completed the Edinburgh Postnatal Depression Scale self-rating psychometric questionnaire. Villous trophoblast tissue samples were analysed for gene expression. Results In a pilot study, diagnosed depression during pregnancy was associated with a significant reduction in placental PEG3 expression (41%, p = 0.02). In two further independent cohorts, the Queen Charlotte's and MBAM cohorts, placental PEG3 expression was also inversely associated with maternal depression scores, an association that was significant in male but not female placentas. Finally, hPL expression was significantly decreased in women with clinically diagnosed depression (44%, p < 0.05) and in those with high depression scores (31% and 21%, respectively). Conclusions This study provides the first evidence that maternal prenatal depression is associated with changes in the placental expression of PEG3, co-incident with decreased expression of hPL. This aberrant placental gene expression could provide a possible mechanistic explanation for the co-occurrence of maternal depression, fetal growth restriction, impaired maternal behaviour and poorer offspring outcomes.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Subjects:	Q Science > QH Natural history > QH426 Genetics
Publisher:	Cambridge University Press
ISSN:	0033-2917
Funders:	BBSRC, MRC
Date of First Compliant Deposit:	6 July 2016
Date of Acceptance:	16 June 2016
Last Modified:	04 May 2023 23:39
URI:	https://orca.cardiff.ac.uk/id/eprint/92383

Citation Data

Cited 32 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item